Last reviewed · How we verify
NCT07172542
High Risk of Death or Disability in Brain Hemorrhage: Role of Spot Sign and Secondary Markers
trial in Intracerebral Hemorrhage in 50 participants. Not yet recruiting.
15 May 2026
Quick facts
| Lead sponsor | Centre Hospitalier de Gonesse |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 50 |
| Start date | 15 October 2025 |
| Primary completion | 15 May 2026 |
| Estimated completion | 15 May 2026 |
| Sites | 1 location across France |
Conditions studied
- Intracerebral Hemorrhage — all drugs for Intracerebral Hemorrhage →
- Cerebral Hemorrhage — all drugs for Cerebral Hemorrhage →
- Stroke — all drugs for Stroke →
- Brain Injuries — all drugs for Brain Injuries →
Sponsor
Centre Hospitalier de Gonesse
Who can join
18 and older, any sex, with Intracerebral Hemorrhage or Cerebral Hemorrhage. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study looks at patients with brain hemorrhage to see if a special sign on brain scans, called the "Spot Sign," combined with other scan features, can predict a higher risk of death or disability. By comparing patient outcomes with existing prediction scores, the study aims to understand whether these scan markers provide extra value in identifying patients at higher risk.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07172542
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Intracerebral Hemorrhage
Currently open trials in the same condition.
- NCT07458880 — Triple Antihypertensive Medication After Intracerebral Hemorrhage for Blood Pressure Control · NA · recruiting
- NCT07365150 — Precision Use of TXA in Intracerebral Hemorrhage · NA · recruiting
- NCT07246473 — Non-invasive Ultrasound and Hematoma Clearance After Intracerebral Hemorrhage · NA · recruiting
- NCT07455201 — Evaluating a Prototype CT Scan for ICH Evacuation · NA · recruiting
- NCT07187687 — TrIal of Early Minimally Invasive Catheter Evacuation With Thrombolysis in IntraCerebral Hemorrhage · NA · recruiting
Other Centre Hospitalier de Gonesse trials
Trials by the same sponsor.
- NCT07122856 — Predictive Factors for Initial MMSE Score and Rapid Decline in Alzheimer's Disease Patients · not yet recruiting
- NCT07064265 — Assessment of Interprofessional Competencies of Healthcare Professionals Before and After Healthcare Simulation Sessions · not yet recruiting
- NCT07122869 — Eligibility of Patients Referred to Emergency Departments by Their General Practitioners for Care in Walk-in Clinics: A · recruiting
- NCT07030036 — Screening for Cognitive Disorders in Multiple Sclerosis · not yet recruiting
- NCT06994026 — Feasibility Study of a Relapse Investigation Questionnaire Administered by an MS Care Coordinator Nurse in Patients With · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07172542 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier de Gonesse
- Last refreshed: 15 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07172542.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing